Table 4: Comparison in the reduction of IOP and medications in both subconjunctival bevacizumab (SCB) and control groups.

SCB group
Control group
value

Final IOP
(mmHg)
14.0 ± 4.711.9 ± 4.70.36
Percentage of IOP reduction20%36%0.73
Final number of medications0.7 ± 1.10.4 ± 0.80.11
Percentage of the reduction of medication use32%27%0.15